Advertisements



Patent ruling positive for Celgene and Bristol-Myers, says Guggenheim

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 11th, 2019

Starboard gauges Bristol-Myers shareholder support for Celgene deal

Activist hedge fund Starboard Value LP has asked a proxy solicitor to probe the level of support among Bristol-Myers Squibb Co shareholders for the U.S. drug maker's $74 billion deal to buy Celgene Corp, people familiar with the matter said on Friday......»»

Category: topSource: reutersFeb 15th, 2019

Celgene/Bristol-Myers: Analyzing The News Of Starboard"s Stake

Celgene/Bristol-Myers: Analyzing The News Of Starboard"s Stake.....»»

Category: topSource: seekingalphaFeb 5th, 2019

Celgene, Bristol-Myers expect to close deal in Q3

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 31st, 2019

Bristol-Myers - Appealing, With Or Without Celgene

Bristol-Myers - Appealing, With Or Without Celgene.....»»

Category: topSource: seekingalphaJan 28th, 2019

Celgene Stock Is Rising After the CEO of AbbVie Ruled Out a Big Deal

There had been speculation that AbbVie might bid for Bristol-Myers Squibb and break up Bristol-Myers’ deal to buy Celgene......»»

Category: topSource: barronsJan 26th, 2019

Jefferies does not see possible Bristol-Myers suitor thwarting Celgene deal

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 22nd, 2019

Bristol-Myers/Celgene: The Spread Is Your Friend

Bristol-Myers/Celgene: The Spread Is Your Friend.....»»

Category: topSource: seekingalphaJan 21st, 2019

The Bristol-Myers Celgene Deal, And Other Ideas

The Bristol-Myers Celgene Deal, And Other Ideas.....»»

Category: topSource: seekingalphaJan 18th, 2019

Bristol-Myers Squibb Stock Issued For Celgene: I Plan To Keep It

Bristol-Myers Squibb Stock Issued For Celgene: I Plan To Keep It.....»»

Category: topSource: seekingalphaJan 15th, 2019

Eli Lilly, Loxo Make More Sense Than Bristol Myers, Celgene

Eli Lilly, Loxo Make More Sense Than Bristol Myers, Celgene.....»»

Category: topSource: seekingalphaJan 14th, 2019

Bristol-Myers: Fattening Up The Pipeline With Celgene

Bristol-Myers: Fattening Up The Pipeline With Celgene.....»»

Category: topSource: seekingalphaJan 13th, 2019

Why Bristol-Myers Squibb Can Be a Sweet Pill for Investors

Wall Street has soured on the deal for Celgene, but Bristol-Myers has one of the lowest valuations in the drug sector and could itself become a takeover target.....»»

Category: topSource: barronsJan 13th, 2019

3 Things Bristol-Myers Squibb Understands About Celgene That the Market Hasn"t

Healthcare s.....»»

Category: futuresSource: nasdaqJan 8th, 2019

The Zacks Analyst Blog Highlights: Bristol-Myers, Celgene, Merck, Pfizer and AbbVie

Zacks.....»»

Category: topSource: redinewsJan 7th, 2019

Celgene provides 2019 profit and sales outlooks above expectations

Celgene Corp. , the biopharmaceutical company that agreed last week to be acquired by Bristol-Myers Squibb Co. in a mega-deal valued at $74 billion, provided 2019 profit and sales outlooks that were above expectations. The company said it expects a.....»»

Category: topSource: marketwatchJan 7th, 2019

Should Investors Like Bristol-Myers" Buyout of Celgene?

The pharmaceutical giant’s $74 billion bid for the biotechnology player sent the acquirer’s shares significantly lower, but that’s hardly unusual......»»

Category: topSource: foxnewsJan 7th, 2019

Why the Bristol-Myers Squibb Acquisition Is a Bad Deal for Celgene

If this proposed acquisition was a game show, it would be called "The Price Isn't Right.".....»»

Category: topSource: foxnewsJan 6th, 2019

Can Bristol-Myers Squibb"s Balance Sheet Handle The Celgene Acquisition?

Can Bristol-Myers Squibb"s Balance Sheet Handle The Celgene Acquisition?.....»»

Category: topSource: seekingalphaJan 6th, 2019

The Week Ahead In Biotech: Conferences, Clinical Trials

The new year kick started with a bumper deal in the pharma space, with Bristol-Myers Squibb Co (NYSE: BMY) agreeing to buy Celgene Corporation (NASDAQ: read more.....»»

Category: blogSource: benzingaJan 6th, 2019

Bristol-Myers Buys Celgene: Smart Plan Or A Rush To Action?

Bristol-Myers Buys Celgene: Smart Plan Or A Rush To Action?.....»»

Category: topSource: seekingalphaJan 4th, 2019